Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study

Fig. 1

Delphi study design. *Total number of questions asked. For some Likert scale questions, multiple options were given, with each analysed separately to assess consensus (e.g. “During the early stages of treatment, paediatric patients should be monitored for the types of symptoms listed below 1–2 times per year. Symptoms: Central and peripheral nervous system; Ocular system; Enterohepatic system; Cognitive performance [e.g. learning difficulties]; Cardiovascular system; Skeletal system; Pulmonary system”, where consensus was assessed separately for each symptom). †For each round, questionnaires were left open for responses in SurveyMonkey until analyses of the results began

Back to article page